Strategic partnership Perceptive combines Calyx and Invicro with a 50-year heritage, offering imaging biomarkers, core lab services, RTSM, analytics, and software across the full R&D lifecycle. Potential sales opportunity: position integrated end-to-end imaging and trial management solutions to pharma and biotech clients seeking streamlined operations and consolidated vendor relationships.

Biotech focus Industry specialization in biotechnology research with capabilities spanning discovery to post-marketing. Potential sales opportunity: tailor solutions for biotech sponsors needing advanced analytics, biomarkers, and bespoke lab services to accelerate development timelines.

Technology stack Tech footprint includes SAP, MySQL, Azure DevOps, Microsoft Excel, OAuth, Java, C++, and Google Tag Manager. Potential sales opportunity: offer integration consulting and custom workflow automation to customers already using similar stacks, emphasizing seamless data flow and security.

Medium-scale reach Headcount 201-500 positions, signaling a mid-market to small-enterprise footprint with growing capacity. Potential sales opportunity: present scalable, cost-effective solutions and flexible engagement models that fit mid-size CROs and biotech firms expanding their R&D programs.

Expansion-ready value Recent branding shift to Perceptive and a broad service portfolio in imaging, core labs, RTSM, analytics, and software indicate readiness for cross-sell and upsell across the R&D lifecycle. Potential sales opportunity: propose multi-service bundles and renewal-focused offerings to existing clients in pharma and biotech seeking performance gains and risk reduction.